IMNM insider transactions

Director Bienaime Jean Jacques sold $203,820 worth of shares (10,500 units at $19.41) and bought $204,260 worth of shares (10,500 units at $19.45) (SEC Form 4)

Director Bienaime Jean Jacques bought $103,500 worth of shares (5,000 units at $20.70), increasing direct ownership by 13% to 43,415 units (SEC Form 4)

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Siegall Clay B

SEC Form 4 filed by Wagenheim Philip

Director Bienaime Jean Jacques bought $43,670 worth of shares (2,000 units at $21.84), increasing direct ownership by 5% to 38,415 units (SEC Form 4)

President and CEO Siegall Clay B bought $100,018 worth of shares (4,729 units at $21.15), increasing direct ownership by 0.72% to 665,254 units (SEC Form 4)

Director Barchas Isaac sold $8,330,080 worth of shares (383,200 units at $21.74) (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 3,000 shares and received a gift of 3,000 shares, decreasing direct ownership by 7% to 37,729 units (SEC Form 4)

President and CEO Siegall Clay B bought $149,053 worth of shares (7,278 units at $20.48) and gifted 200,000 shares, decreasing direct ownership by 23% to 660,525 units (SEC Form 4)

Chief Technical Officer Tsai Philip bought $204,900 worth of shares (10,000 units at $20.49), increasing direct ownership by 30% to 43,300 units (SEC Form 4)

President and CEO Siegall Clay B bought $999,986 worth of shares (46,511 units at $21.50), increasing direct ownership by 6% to 853,247 units (SEC Form 4)

Chief Scientific Officer Higgins Jack exercised 22,000 shares at a strike of $1.35, increasing direct ownership by 117% to 40,729 units (SEC Form 4)

SEC Form 4 filed by Chief Technical Officer Tsai Philip

SEC Form 4 filed by Chief Financial Officer Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Barchas Isaac

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Swain Sandra M

Director Bienaime Jean Jacques bought $46,900 worth of shares (5,000 units at $9.38), increasing direct ownership by 16% to 36,415 units (SEC Form 4)

Chief Scientific Officer Higgins Jack exercised 5,200 shares at a strike of $1.35, increasing direct ownership by 38% to 18,729 units (SEC Form 4)

Director Bienaime Jean Jacques bought $60,684 worth of shares (7,800 units at $7.78), increasing direct ownership by 33% to 31,415 units (SEC Form 4)

President and CEO Siegall Clay B bought $999,459 worth of shares (137,100 units at $7.29), increasing direct ownership by 20% to 806,736 units (SEC Form 4)

Director Bienaime Jean Jacques bought $57,470 worth of shares (7,000 units at $8.21), increasing direct ownership by 42% to 23,615 units (SEC Form 4)

Chief Technology Officer Tsai Philip bought $103,566 worth of shares (12,300 units at $8.42), increasing direct ownership by 59% to 33,300 units (SEC Form 4)

President and CEO Siegall Clay B bought $1,162,500 worth of shares (150,000 units at $7.75), increasing direct ownership by 29% to 669,636 units (SEC Form 4)

President and CEO Siegall Clay B bought $962,181 worth of shares (100,000 units at $9.62), increasing direct ownership by 24% to 519,636 units (SEC Form 4)

Chief Medical Officer Lechleider Robert bought $149,800 worth of shares (15,805 units at $9.48) (SEC Form 4)

Chief Technology Officer Tsai Philip bought $198,030 worth of shares (21,000 units at $9.43) (SEC Form 4)

Chief Financial Officer Rosett Max exercised 42,000 shares at a strike of $1.05 and sold $230,224 worth of shares (14,380 units at $16.01), increasing direct ownership by 139% to 47,476 units (SEC Form 4)

Director Bienaime Jean Jacques bought $97,608 worth of shares (7,000 units at $13.94), increasing direct ownership by 73% to 16,615 units (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 2,471 shares, exercised 19,524 shares at a strike of $1.35 and sold $49,072 worth of shares (3,524 units at $13.93) (SEC Form 4)

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Strategy Officer Turner Bruce

SEC Form 4 filed by EVP, Operations & CFO Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by Chief Technology Officer Tsai Philip

SEC Form 3 filed by new insider Tsai Philip

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Swain Sandra M

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Barchas Isaac

Bienaime Jean Jacques bought $27,140 worth of shares (2,000 units at $13.57), increasing direct ownership by 26% to 9,615 units (SEC Form 4)

Siegall Clay B bought $1,388,072 worth of shares (100,000 units at $13.88), increasing direct ownership by 31% to 419,636 units (SEC Form 4)

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Swain Sandra M